小儿咳喘灵口服液联合易坦静治疗支气管肺炎临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563.1+2;R473.72

基金项目:


Clinical Study on Xiao'er Kechuanling Oral Solution Combined with Yitanjing for Bronchopneumonia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察小儿咳喘灵口服液联合易坦静治疗支气管肺炎的临床效果。方法:将支气管肺炎患儿 108 例随机分为观察组与对照组,各 54 例。2 组均给予优质护理干预,对照组应用易坦静治疗,观察组在对照组的基础上联合小儿咳喘灵口服液治疗。比较 2 组临床总有效率、第 1 秒用力呼气容积 (FEV1)、用力肺活量 (FVC)、呼吸气流量分值 (PEF)、病情改善用时、不良反应情况。结果:观察组总有效率为 96.30%,对照组为 74.07%,2 组比较,差异有统计学意义 (P<0.05)。治疗后,2 组FEV1、FVC、PEF 均较治疗前升高(P<0.05),且观察组上述指标均高于对照组(P<0.05)。观察组患儿退热、咳嗽停止、肺部湿啰音消失、喘息消失用时均短于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率为 3.70%,对照组为 5.56%, 2 组比较,差异无统计学意义(P>0.05)。结论:小儿咳喘灵口服液联合易坦静治疗支气管肺炎患儿疗效显著,结合优质护理干预可有效改善患儿肺功能及临床症状。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Xiao'er Kechuanling oral solution combined with Yitanjing for bronchopneumonia. Methods: A total of 108 cases of children with bronchopneumonia were randomly divided into the observation group and the control group,54 cases in each group. Both groups were given high-quality nursing intervention; the control group was treated with Yitanjing,and the observation group was additionally treated with Xiao'er Kechuanling oral solution based on the treatment of the control group. The total effective rates,forced expiratory volume in the first second (FEV1),forced vital capacity(FVC),peak expiratory flow(PEF),the time for disease improvement,and adverse reactions in the two groups were compared. Results:The total effective rate was 96.30% in the observation group and 74.07% in the control group,the difference being significant(P<0.05). After treatment,FEV1,FVC and PEF in the two groups were all increased when compared with those before treatment(P<0.05),and the above indexes in the observation group were all higher than those in the control group(P<0.05). The antipyretic time,the stopping time of coughing and the disappearance time of moist rales and wheezing in the observation group were shorter than those in the control group,the difference being significant(P<0.05). The incidence of adverse reactions was 3.70% in the observation group and 5.56% in the control group, there being no significant difference between the two groups(P>0.05). Conclusion:The therapy of Xiao'er Kechuanling oral solution combined with Yitanjing has significant curative effect in treating children with bronchopneumonia. The combining intervention of high-quality nursing can effectively improve their lung function and clinical symptoms.

    参考文献
    相似文献
    引证文献
引用本文

张秀丽.小儿咳喘灵口服液联合易坦静治疗支气管肺炎临床研究[J].新中医,2021,53(4):178-181

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-27
  • 出版日期: